Peregrine Pharmaceuticals | PPHM - Action



Action Changement Date
Amgen USD 6.22B 121M 2025-12
AstraZeneca USD 6.59B 126M 2025-09
BioCryst Pharmaceuticals USD 5.4M 166K 2025-12
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Eli Lilly USD 13.74B 1.56B 2025-12
GlaxoSmithKline GBP 6.12B 46M 2025-09
Intrexon USD 287K 68K 2022-12
Karyopharm Therapeutics USD 4.04M 72K 2025-12
MacroGenics USD 7.91M 840K 2025-12
MannKind USD 35.31M 8.34M 2025-12
Merck USD 6.44B 157M 2025-09
Novartis USD 6.42B 114M 2025-09
Novavax USD 11.54M 1.97M 2025-12
Repligen USD 170.46M 10.14M 2025-12
Roche Holding CHF 7.6B 9M 2025-06